We are live on
!
Find out more
ACM
Acrisure Capital Management Portfolio holdings
AUM
$98.8M
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90.3M
AUM Growth
–
Cap. Flow
+$90.7M
Cap. Flow
% of AUM
100.45%
Top 10 Holdings %
Top 10 Hldgs %
12.97%
Holding
254
New
254
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.3M |
| 2 |
MRSH
Marsh
MRSH
|
+$1.27M |
| 3 |
First Interstate BancSystem
FIBK
|
+$1.26M |
| 4 |
PepsiCo
PEP
|
+$1.23M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$1.18M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.57% |
| 2 | Utilities | 10.8% |
| 3 | Industrials | 10.18% |
| 4 | Consumer Staples | 9.8% |
| 5 | Healthcare | 8.85% |
Similar funds
RA
CWM
ETM
HLCM
CFA
ACM
UPC
AMC
Acrisure Capital Management's Q4 2022 Portfolio in Review
Q4 2022 is the first quarter with a 13F filing on record for Acrisure Capital Management, which disclosed 254 positions worth $90.3M. Its ten largest holdings account for 13% of the portfolio.
Its largest position is Johnson & Johnson: 7,518 shares worth $1.33M.
By sector, the portfolio is most concentrated in Financials at 33% of assets, followed by Utilities and Industrials.
- Acrisure Capital Management's largest Q4 2022 buy was Johnson & Johnson: 7,518 shares worth $1.33M.
- Acrisure Capital Management's ten largest holdings make up 13% of its $90.3M portfolio in Q4 2022.
- Acrisure Capital Management disclosed 254 positions in Q4 2022, its first 13F filing on record.
Based on Acrisure Capital Management's 13F filing for Q4 2022, filed 28 Mar 2023.